Latest Posts

Category: Press release older

Innoplexus, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others

Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in the sum of double-digit millions. The round was co-led by FinLab EOS VC Fund, a venture capital fund backed by both Block.one, the publisher of …

Innoplexus, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others Read More »

Innoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies

Insights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the publication of a new study examining consumer perceptions about drug prices, transparency, and other issues related to the pharmaceutical industry. This survey …

Innoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies Read More »

Accelerating innovation in Pharma with Artificial Intelligence & Big Data

As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for life sciences and pharmaceutical industries. A lot still relies upon data while conducting research which is mostly done through traditional methods. As many top notch business …

Accelerating innovation in Pharma with Artificial Intelligence & Big Data Read More »

Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India

Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexus platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexus. Doctors and researchers will be able to gain insights into the latest …

Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India Read More »

German VC firm invests in Data as a Service startup Innoplexus

Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexus, and invest in marketing.

0